Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma
NCT07729098
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Chronic Subdural Hematoma
Interventions
DRUG:
Bevacizumab (intra-arterial)
Sponsor
Dheeraj Gandhi